Pharm Tech Europe - Home Page
 

ADVERTISEMENT

Jul 4, 2009
Make This Page Your Home Page!
Survey
What type of pharmaceutical research news are you most interested in?
Drug discovery
Clinical trials
Post-marketing research
Drug discovery
56%
Clinical trials
22%
Post-marketing research
22%
View Results
PTE magazine audited by:

Previous StoryPlay / PauseNext Story
July 2009
APIs
The 'pepper pot' principle: ensuring the most effective drugs reach the market faster
By: Robin Mitchell, David Edwards
Information technology
Pharma's Facebook
By: Peter Houston
Analytical
Dynamic avalanching accurately assesses flowability and quality
By: Riccardo Bonfichi, Giulia Cloralio, Andrea Rainoldi
Regulatory
Are we moving towards global patenting?
Business
The Pharma Top 50
Manufacturing & Processing
Nanotechnology: the next silver bullet?
By: Mike Fisher
Biopharmaceuticals
Expression systems royalties battle
By: Eric S. Langer
Outsourcing review
Penny-wise, pound-foolish
By: Jim Miller
Spotlight
EU and US unite against rare diseases
By: Faiz Kermani
Ask the Expert
Human error costs industry billions
By: Mary Clarke
Talking Point
Thinking of theranostics?
By: Ian Fitzpatrick
News
News
Editor's Comment
We invite you to Link in
By: Fedra Pavlou
June 2009
Supply chain
Substandard APIs: we must tackle the problem together
By: Guy Villax
Why we need mass serialization — now!
By: Gary Noon
Filtration
Improving liposome integrity and easing bottlenecks to production
By: Priyabrata Pattnaik, Tathagata Ray
Drug Delivery
Formulation effects on the thermomechanical properties and permeability of free films and coating films
By: Jinghua Yuan, Doug Dunn, Nancy M. Clipse, Ray J. Newton, Jr
Validation
Taking the modular approach
By: Brian Collins, Victor Bornsztejn
Biopharmaceuticals
New expression systems create opportunities for innovators, CMOs and product developers
By: Eric Langer
Spotlight
The R&D hurdles for neglected diseases
By: Faiz Kermani
Outsourcing review
Limits to CRO growth?
By: Jim Miller
Talking Point
Where have we reached with REACH?
By: Torben Nörlem
News
News
Editor's Comment
Super heroes, super show
By: Fedra Pavlou
Click here